• Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials
patient education

Q & A Facts on Hydroxyurea for Children With Sickle Cell Disease

key information

source: oneSCDvoice

year: 2020


It is time to rethink hydroxyurea for the treatment of sickle cell disease, especially for your children. Hydroxyurea is a critical therapeutic treatment for children with recurring acute pain events. It has shown to deliver long-term benefits such as the prevention of organ damage.

Who is the Best Candidate for Hydroxyurea?
Children over two years old with sickle cell disease who have recurring and severe pain events (vaso-occlusive crises) are strong candidates for treatment with hydroxyurea.

How Old Does My Child Need to Be to Start Taking Hydroxyurea?
Hydroxyurea has been approved for use in children as young as 2 years old.

Is Hydroxyurea Difficult to Administer?
No. For children and adolescents, a pill a day with water is easy. Hydroxyurea comes as a tablet that quickly melts in water. It is important to understand that in order to get maximum benefit, hydroxyurea must be taken every day. As a parent or caregiver, it is important to commit to the recommended daily dosage. Daily dosage is based on your child’s body weight. It will target an optimal response with fewer side effects, which will help ease your child’s discomfort.


read more

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.